NeuroSense Therapeutics Ltd. – NASDAQ:NRSN

NeuroSense Therapeutics Ltd. stock price today

$1.17
-0.11
-8.59%
Financial Health
0
1
2
3
4
5
6
7
8
9

NeuroSense Therapeutics Ltd. stock price monthly change

+26.73%
month

NeuroSense Therapeutics Ltd. stock price quarterly change

+26.73%
quarter

NeuroSense Therapeutics Ltd. stock price yearly change

+71.81%
year

NeuroSense Therapeutics Ltd. key metrics

Market Cap
25.20M
Enterprise value
N/A
P/E
N/A
EV/Sales
N/A
EV/EBITDA
N/A
Price/Sales
N/A
Price/Book
N/A
PEG ratio
N/A
EPS
-0.86
Revenue
N/A
EBITDA
-10.68M
Income
-12.79M
Revenue Q/Q
N/A
Revenue Y/Y
N/A
Profit margin
0%
Oper. margin
0%
Gross margin
0%
EBIT margin
0%
EBITDA margin
N/A
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

NeuroSense Therapeutics Ltd. stock price history

NeuroSense Therapeutics Ltd. stock forecast

NeuroSense Therapeutics Ltd. financial statements

NeuroSense Therapeutics Ltd. (NASDAQ:NRSN): Profit margin
Jun 2023 0 -5.22M
Sep 2023 0 784K
Dec 2023 0 -2.95M
Mar 2024 0 -5.40M
NeuroSense Therapeutics Ltd. (NASDAQ:NRSN): Analyst Estimates
2025 0 -15.17M
2026 11.47M -8.11M -70.73%
2027 23.07M 1.50M 6.5%
2028 37.13M 7.91M 21.31%
  • Analysts Price target

  • Financials & Ratios estimates

NeuroSense Therapeutics Ltd. (NASDAQ:NRSN): Earnings per share (EPS)
2024-03-22 -0.2 -0.16
2024-04-05 -0.2 -0.16
2024-08-28 -0.2 -0.04747
2024-12-18 -0.16 -0.11
NeuroSense Therapeutics Ltd. (NASDAQ:NRSN): Debt to assets
Jun 2023 7868000 9.41M 119.64%
Sep 2023 5386000 5.58M 103.64%
Dec 2023 3176000 5.05M 159.01%
Mar 2024 1446000 8.43M 583.61%
NeuroSense Therapeutics Ltd. (NASDAQ:NRSN): Cash Flow
Mar 2023 0 0 0
Jun 2023 1.78K 0 0
Sep 2023 0 0 0
Dec 2023 0 0 0

NeuroSense Therapeutics Ltd. alternative data

NeuroSense Therapeutics Ltd. (NASDAQ:NRSN): Employee count
Aug 2023 14
Sep 2023 14
Oct 2023 14
Nov 2023 14
Dec 2023 14
Jan 2024 14
Feb 2024 14
Mar 2024 14
Apr 2024 14
May 2024 18
Jun 2024 18
Jul 2024 18

NeuroSense Therapeutics Ltd. other data

1.10% +0.79%
of NRSN is owned by hedge funds
123.81K +89.11K
shares is hold by hedge funds
Monday, 23 December 2024
prnewswire.com
Wednesday, 18 December 2024
prnewswire.com
Wednesday, 11 December 2024
prnewswire.com
Wednesday, 4 December 2024
prnewswire.com
Monday, 2 December 2024
prnewswire.com
Thursday, 21 November 2024
prnewswire.com
Monday, 28 October 2024
prnewswire.com
Thursday, 24 October 2024
prnewswire.com
Tuesday, 15 October 2024
prnewswire.com
Wednesday, 9 October 2024
prnewswire.com
Monday, 7 October 2024
prnewswire.com
Tuesday, 24 September 2024
prnewswire.com
prnewswire.com
Friday, 30 August 2024
prnewswire.com
Wednesday, 7 August 2024
prnewswire.com
Thursday, 1 August 2024
prnewswire.com
Tuesday, 9 July 2024
prnewswire.com
Tuesday, 2 July 2024
marketwatch.com
Monday, 1 July 2024
prnewswire.com
Monday, 24 June 2024
prnewswire.com
Friday, 21 June 2024
prnewswire.com
Monday, 20 May 2024
prnewswire.com
Tuesday, 14 May 2024
prnewswire.com
Tuesday, 7 May 2024
prnewswire.com
Thursday, 2 May 2024
prnewswire.com
Monday, 22 April 2024
prnewswire.com
Thursday, 18 April 2024
prnewswire.com
Friday, 12 April 2024
PRNewsWire
Thursday, 9 November 2023
PRNewsWire
Friday, 6 October 2023
Seeking Alpha
  • What's the price of NeuroSense Therapeutics Ltd. stock today?

    One share of NeuroSense Therapeutics Ltd. stock can currently be purchased for approximately $1.17.

  • When is NeuroSense Therapeutics Ltd.'s next earnings date?

    Unfortunately, NeuroSense Therapeutics Ltd.'s (NRSN) next earnings date is currently unknown.

  • Does NeuroSense Therapeutics Ltd. pay dividends?

    No, NeuroSense Therapeutics Ltd. does not pay dividends.

  • How much money does NeuroSense Therapeutics Ltd. make?

    NeuroSense Therapeutics Ltd. has a market capitalization of 25.20M. NeuroSense Therapeutics Ltd. made a loss 10.11M US dollars in net income (profit) last year or -$0.11 on an earnings per share basis.

  • What is NeuroSense Therapeutics Ltd.'s stock symbol?

    NeuroSense Therapeutics Ltd. is traded on the NASDAQ under the ticker symbol "NRSN".

  • What is NeuroSense Therapeutics Ltd.'s primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of NeuroSense Therapeutics Ltd.?

    Shares of NeuroSense Therapeutics Ltd. can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • How many employees does NeuroSense Therapeutics Ltd. have?

    As Jul 2024, NeuroSense Therapeutics Ltd. employs 18 workers, which is 29% more then previous quarter.

  • When NeuroSense Therapeutics Ltd. went public?

    NeuroSense Therapeutics Ltd. is publicly traded company for more then 3 years since IPO on 9 Dec 2021.

  • What is NeuroSense Therapeutics Ltd.'s official website?

    The official website for NeuroSense Therapeutics Ltd. is neurosense-tx.com.

  • How can i contact NeuroSense Therapeutics Ltd.?

    NeuroSense Therapeutics Ltd. can be reached via phone at +972 9 799 6183.

NeuroSense Therapeutics Ltd. company profile:

NeuroSense Therapeutics Ltd.

neurosense-tx.com
Exchange:

NASDAQ

Full time employees:

18

Industry:

Biotechnology

Sector:

Healthcare

NeuroSense Therapeutics Ltd., a clinical-stage biotechnology company, focuses on the discovery and development of treatment for patients suffering from debilitating neurodegenerative diseases. Its lead product, PrimeC, is a novel oral formulation that has completed Phase IIa clinical trials for the treatment of amyotrophic lateral sclerosis. The company's preclinical pipeline includes StabiliC for the treatment of Parkinson's disease; and CogniC for the treatment of Alzheimer's disease. NeuroSense Therapeutics Ltd. was incorporated in 2017 and is headquartered in Herzliya, Israel.

Building B
Herzliya, 4672562

CIK: 0001875091
ISIN: IL0011809592
CUSIP: M74240108